Mangoceuticals Inc (MGRX)

$0.16 -0.19 (-54.51%)
Market Cap 6.52M
Revenue (ttm) 620,000.00
Net Income (ttm) -8.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,404.84%
Debt to Equity Ratio 0.00
Volume 3,851,700
Avg Vol 8,745,998
Day's Range N/A - N/A
Shares Out 16.29M
Stochastic %K 0%
Beta 2.33
Analysts Strong Buy
Price Target N/A

Company Profile

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low testosterone in men and as a form of testosterone...

Industry: Health Information Services
Sector: Healthcare
Phone: 214 242 9619
Address:
15110 N. Dallas Parkway, Suite 600, Dallas, United States
BullishReactions
BullishReactions Mar. 21 at 8:06 PM
$MGRX monday could continue
0 · Reply
bundy3333
bundy3333 Mar. 21 at 7:51 PM
$MGRX assuming every cent less than 40 cent is punishment of not releasing any ER for 2025 every cent less than 30 cent because of the so called joke with the senseless court filing every cent less than 20 cent because of eventually be aware of the board decisions from March, 16th (see SEC filing plus the resulting SEC filing from 03/20) Let's give the Roulette Ball another chance on Monday by AH at the latest for colours green / red or tilt / black Everything between tilt and 85 cent might be possible till March, 24th AH ...
0 · Reply
TradingUK
TradingUK Mar. 21 at 7:36 PM
$ABVE $AIFF $MGRX $RPGL $SUNE Paul knows ABVE is going to fucking moon ❤️🍌📈
0 · Reply
PaulLaurent
PaulLaurent Mar. 21 at 7:32 PM
🌅 4:00am EST Watchlist — March 23, 2026 $ABVE – Above Food Ingredients said it expects to provide a full update on its Fiscal 2025 audit and related Form 20-F during the week of March 23. Management also addressed insider-selling speculation, saying insiders have not sold, pledged, or hedged shares, while the company remains within Nasdaq’s filing-extension window. 📋 $MGRX – No confirmed headline tied to the AH move. This looks momentum and scanner-driven, with thin after-hours liquidity likely helping exaggerate the spike. ⚠️ $AIFF – Another after-hours runner without a confirmed fresh company-specific catalyst. Traders will be watching whether momentum carries into premarket or fades once liquidity normalizes. Potential multi-day runners: $SUNE ✅ $RPGL ✅
0 · Reply
ReversalTrack
ReversalTrack Mar. 21 at 6:39 PM
JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $MGRX $CHGG $AIFF $ABVE hot looks.
1 · Reply
giancachimi
giancachimi Mar. 21 at 6:06 PM
$AIFF $ABVE $MGRX $ARBB
0 · Reply
Vagabull
Vagabull Mar. 21 at 6:03 PM
$MGRX did someone get margin called or have to liquidate assets?
0 · Reply
giancachimi
giancachimi Mar. 21 at 5:47 PM
$ABVE $ANNA $MGRX $AZTR $SMCI
0 · Reply
TradingUK
TradingUK Mar. 21 at 8:39 AM
$ABVE Happy Saturday ❤️ Next week is going to be epic fury 🍌🍌📈📈 Make sure your early on Monday $ANNA $MGRX $AZTR $SMCI
1 · Reply
lenhat
lenhat Mar. 20 at 10:43 PM
$MGRX short sellers be punished on Monday very sure. Imagine if they win the lawsuit💪💪💪
1 · Reply
Latest News on MGRX
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.

Mar 17, 2026, 4:00 PM EDT - 4 days ago

Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

Mar 6, 2026, 4:00 PM EST - 15 days ago

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds

Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

Feb 23, 2026, 4:05 PM EST - 26 days ago

Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Feb 20, 2026, 3:40 PM EST - 4 weeks ago

Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally?

Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model

Feb 20, 2026, 9:59 AM EST - 4 weeks ago

Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Feb 19, 2026, 4:05 PM EST - 4 weeks ago

MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Dec 19, 2025, 10:38 AM EST - 3 months ago

Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

Dec 19, 2025, 7:30 AM EST - 3 months ago

Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy

Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules

Dec 18, 2025, 8:30 AM EST - 3 months ago

Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Nov 13, 2025, 7:37 PM EST - 4 months ago

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

Nov 13, 2025, 2:04 PM EST - 4 months ago

Novo Nordisk, Lilly deny partnership with Mangoceuticals on obesity drugs

LLY NVO

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

Nov 13, 2025, 7:15 AM EST - 4 months ago

Mangoceuticals partners with Lilly, Novo Nordisk to sell weight-loss drugs

LLY NVO

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

May 27, 2025, 9:00 AM EDT - 10 months ago

Mangoceuticals' Patented MGX-0024 Delivers 100% Respiratory Survival in Poultry Studies Signaling Strong Potential Defense Against Spread of Avian Flu

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

Apr 28, 2025, 9:36 AM EDT - 11 months ago

ArcStone Securities and Investments Corp. Publishes Industry Report on The Rapid Expansion of The Oral Stimulant Pouch Market

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 26, 2025, 10:54 AM EDT - 11 months ago

CORRECTION FROM SOURCE: ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of IP Assets of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Apr 25, 2025, 10:26 AM EDT - 11 months ago

ArcStone Securities and Investments Corp. Serves as Exclusive Financial Advisor to Mangoceuticals Inc. (MGRX) on its Transformative Acquisition of Smokeless Technology Corp. Marking its Entry into the High Growth Oral Stimulant Pouch Sector

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Apr 25, 2025, 9:00 AM EDT - 11 months ago

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Apr 22, 2025, 1:55 PM EDT - 11 months ago

CEO Spotlight: How Mangoceuticals Inc. is Reinventing The Personal Health Landscape

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Feb 3, 2025, 8:30 AM EST - 1 year ago

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

Dec 19, 2024, 5:33 PM EST - 1 year ago

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Oct 21, 2024, 5:10 PM EDT - 1 year ago

MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

Oct 18, 2024, 8:45 AM EDT - 1 year ago

Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

Oct 11, 2024, 5:15 PM EDT - 1 year ago

MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

Oct 3, 2024, 8:30 AM EDT - 1 year ago

MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

Oct 1, 2024, 7:30 AM EDT - 1 year ago

MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

Aug 15, 2024, 9:25 AM EDT - 1 year ago

MangoRx Reports 1,685% Increase in Shareholders' Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

Aug 9, 2024, 8:15 AM EDT - 1 year ago

MangoRx Completes Migration to DEA-Approved Telemedicine Platform, Accelerating Timeline of Oral Dissolvable GLP-1 Weight Loss Treatments Featuring Semaglutide and Tirzepatide

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

Aug 8, 2024, 8:30 AM EDT - 1 year ago

MangoRx Receives Request for Proposal (RFP) From ISFLST for New Male Enhancement Product Exclusive for the Asian Market

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Jul 24, 2024, 8:15 AM EDT - 1 year ago

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

Jul 18, 2024, 4:05 PM EDT - 1 year ago

Mangoceuticals CEO Jacob Cohen Featured on Benzinga All-Access

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

Jul 16, 2024, 8:20 AM EDT - 1 year ago

MangoRx Secures DEA Approval for Proprietary HIPAA-Compliant Operating System via Surescripts

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

Jul 12, 2024, 1:30 PM EDT - 1 year ago

MangoRx Appoints Dr. Douglas Christianson, N.D. as Director of the Medical Research and Product Innovation Department

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

Jul 11, 2024, 8:15 AM EDT - 1 year ago

MangoRx Announces Strategic Partnership for Expansion into Asia Pacific and Key Emerging Markets

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

Jun 6, 2024, 8:30 AM EDT - 1 year ago

MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

Jun 4, 2024, 4:00 PM EDT - 1 year ago

MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

May 28, 2024, 8:30 AM EDT - 1 year ago

Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

May 23, 2024, 8:30 AM EDT - 1 year ago

MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

May 21, 2024, 8:30 AM EDT - 1 year ago

MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

May 16, 2024, 4:40 PM EDT - 2 years ago

MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

May 2, 2024, 8:00 AM EDT - 2 years ago

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

Apr 12, 2024, 8:45 AM EDT - 2 years ago

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

Mar 12, 2024, 9:00 AM EDT - 2 years ago

MangoRx Officially Launches ‘PRIME' by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

Feb 20, 2024, 9:00 AM EST - 2 years ago

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE

Feb 6, 2024, 9:00 AM EST - 2 years ago

MANGORX TO OFFER THE BIG GAME'S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

Feb 5, 2024, 8:50 AM EST - 2 years ago

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

Jan 19, 2024, 8:00 AM EST - 2 years ago

MangoRx's Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Dec 15, 2023, 10:39 AM EST - 2 years ago

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

Dec 13, 2023, 7:30 AM EST - 2 years ago

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

Dec 6, 2023, 8:00 AM EST - 2 years ago

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

Nov 29, 2023, 8:30 AM EST - 2 years ago

Mangoceuticals Selects TRYBE Labs as its Nationwide Blood Collection and Testing Services Provider

BullishReactions
BullishReactions Mar. 21 at 8:06 PM
$MGRX monday could continue
0 · Reply
bundy3333
bundy3333 Mar. 21 at 7:51 PM
$MGRX assuming every cent less than 40 cent is punishment of not releasing any ER for 2025 every cent less than 30 cent because of the so called joke with the senseless court filing every cent less than 20 cent because of eventually be aware of the board decisions from March, 16th (see SEC filing plus the resulting SEC filing from 03/20) Let's give the Roulette Ball another chance on Monday by AH at the latest for colours green / red or tilt / black Everything between tilt and 85 cent might be possible till March, 24th AH ...
0 · Reply
TradingUK
TradingUK Mar. 21 at 7:36 PM
$ABVE $AIFF $MGRX $RPGL $SUNE Paul knows ABVE is going to fucking moon ❤️🍌📈
0 · Reply
PaulLaurent
PaulLaurent Mar. 21 at 7:32 PM
🌅 4:00am EST Watchlist — March 23, 2026 $ABVE – Above Food Ingredients said it expects to provide a full update on its Fiscal 2025 audit and related Form 20-F during the week of March 23. Management also addressed insider-selling speculation, saying insiders have not sold, pledged, or hedged shares, while the company remains within Nasdaq’s filing-extension window. 📋 $MGRX – No confirmed headline tied to the AH move. This looks momentum and scanner-driven, with thin after-hours liquidity likely helping exaggerate the spike. ⚠️ $AIFF – Another after-hours runner without a confirmed fresh company-specific catalyst. Traders will be watching whether momentum carries into premarket or fades once liquidity normalizes. Potential multi-day runners: $SUNE ✅ $RPGL ✅
0 · Reply
ReversalTrack
ReversalTrack Mar. 21 at 6:39 PM
JAGU✅ uranium+rare earth play, Keep this high on watch for next week. JAGU sits right in the middle of: •⚛️ Energy crisis (uranium) •🛰️ Defense tech (rare earths) •🌍 Geopolitical supply shift -The world is entering a resource war and most people still don’t see it Critical minerals uranium and rare earths are now essential for defense energy AI and every advanced system the future depend -Uranium and rare earths are needed in the war and in all things needed in the future, and the US will be flooding billions into South America, exactly where jaguar is.JAGU sitting right where the money is going. US pushing billions into critical minerals in Latin America Argentina becoming a key supply hub And JAGU already has exposure there… Rare earth + uranium + IPO reset = serious setup. $MGRX $CHGG $AIFF $ABVE hot looks.
1 · Reply
giancachimi
giancachimi Mar. 21 at 6:06 PM
$AIFF $ABVE $MGRX $ARBB
0 · Reply
Vagabull
Vagabull Mar. 21 at 6:03 PM
$MGRX did someone get margin called or have to liquidate assets?
0 · Reply
giancachimi
giancachimi Mar. 21 at 5:47 PM
$ABVE $ANNA $MGRX $AZTR $SMCI
0 · Reply
TradingUK
TradingUK Mar. 21 at 8:39 AM
$ABVE Happy Saturday ❤️ Next week is going to be epic fury 🍌🍌📈📈 Make sure your early on Monday $ANNA $MGRX $AZTR $SMCI
1 · Reply
lenhat
lenhat Mar. 20 at 10:43 PM
$MGRX short sellers be punished on Monday very sure. Imagine if they win the lawsuit💪💪💪
1 · Reply
BearBullRunner
BearBullRunner Mar. 20 at 10:39 PM
$MGRX Before I buy is this stock going to be dekisted on Monday? Anybody
1 · Reply
jirishman
jirishman Mar. 20 at 10:24 PM
$MGRX now over 3 million for the day.
2 · Reply
The_Assassin
The_Assassin Mar. 20 at 10:10 PM
Final AI Scanner List $MGRX $ABVE
0 · Reply
Pain_without_Mercy
Pain_without_Mercy Mar. 20 at 10:08 PM
$MGRX found now around 60-70 stocks where the SP in the last seconds before the bell 25-50% dropped. Never saw things like this before. Any idea?
0 · Reply
snugmunchkin
snugmunchkin Mar. 20 at 10:01 PM
$MGRX Jesus, what happened?
0 · Reply
ragzroid
ragzroid Mar. 20 at 9:51 PM
$MGRX should of average down when it went to .2
0 · Reply
jirishman
jirishman Mar. 20 at 9:12 PM
$MGRX this thing has had 2 million shares traded AH….
3 · Reply
TradingUK
TradingUK Mar. 20 at 9:04 PM
$ABVE Would you look at that - It’s like someone tried to shake us all out 😂😂 News is 1000000000% coming next week get in whilst it’s still cheap HUGE HUGE NEWS TO BE ANNOUNCED $ANNA $AZTR $MGRX
1 · Reply
TakeChancesAndWin
TakeChancesAndWin Mar. 20 at 9:03 PM
$AIFF $ABVE $MGRX moving to $ARBB now
0 · Reply
bundy3333
bundy3333 Mar. 20 at 9:00 PM
$NOTV well here we have the 2025 cyber incident with potential theft of all relevant data of studies et all As well the potential cancellation of the credit(s) by tonight $MGRX is missing the ER of 2025 and the ER 2024 stated the going concert alert ( March 19th 2025) AAs well
0 · Reply
BeachbumInvestor
BeachbumInvestor Mar. 20 at 8:47 PM
$MGRX no Boners here. Lol No Homo 🤣
0 · Reply
Pain_without_Mercy
Pain_without_Mercy Mar. 20 at 8:43 PM
$MGRX At least we are on top of the top gainers list.... lol
0 · Reply